Correction: Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

[This corrects the article DOI: 10.1371/journal.pone.0201956.].

Saved in:
Bibliographic Details
Published in:PloS one 2022-04, Vol.17 (4), p.e0261932-e0261932
Main Authors: Tajiri, Hitoshi, Motoya, Satoshi, Kinjo, Fukunori, Maemoto, Atsuo, Matsumoto, Takayuki, Sato, Noriko, Yamada, Hiroshi, Nagano, Mieko, Susuta, Yutaka, Ozaki, Kunihiko, Kondo, Kazuoki, Hibi, Toshifumi
Format: Article
Language:English
Subjects:
Children
Health aspects
Infliximab
Pediatrics
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[This corrects the article DOI: 10.1371/journal.pone.0201956.].
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0261932